Related Experiment Videos
Adverse effect of splenectomy in experimental peritonitis
The Journal of Surgical Research
|June 1, 1985
Summary
Splenectomy increases mortality in fecal peritonitis. Antibiotic (cefoxitin) and immunomodulator (glucan) therapies improve survival, though their combined effect is not superior to cefoxitin alone.
Area of Science:
- Surgical Research
- Immunology
- Microbiology
Background:
- Splenectomy is associated with increased operative morbidity and mortality.
- Polymicrobial fecal peritonitis presents a significant clinical challenge.
Purpose of the Study:
- To assess the impact of splenectomy on mortality in a rat model of fecal peritonitis.
- To evaluate the therapeutic efficacy of cefoxitin (antibiotic) and glucan (immunomodulator) in this model.
Main Methods:
- Sprague-Dawley rats underwent splenectomy or sham surgery followed by peritoneal inoculation with stool-barium.
- Treatment groups included 5% dextrose, cefoxitin, glucan, or cefoxitin plus glucan.
- Bacterial cultures, leukocyte counts, and intravascular clearance assays were performed.
Main Results:
- Splenectomy significantly decreased survival rates (5% vs. 30%).
- Cefoxitin (90%) and glucan (47%) treatments markedly improved survival.
- Cefoxitin reduced bacterial growth; glucan decreased bloodborne bacteria. Splenectomy lowered leukocyte counts.
Conclusions:
- Splenectomy exacerbates mortality in fecal peritonitis.
- Both antibiotic and immunomodulatory treatments offer protection against mortality.
- The precise mechanisms underlying the protective effects require further elucidation.